TEVA EBITDA
Teva Pharmaceutical Industries Limited American Depositary Shares · EBITDA
TEVA EBITDA
Latest reported$2.59Bperiod ending
TEVA EBITDA ($15.40M → $2.59B)
Annual EBITDA
High-resolution chart · PNG
TEVA ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 3,141,000,000 | |
| 4,431,000,000 | |
| 1,558,000,000 | |
| -925,000,000 | |
| 4,409,000,000 | |
| 4,612,000,000 | |
| 4,438,000,000 | |
| 186,000,000 | |
| -15,480,000,000 | |
| 2,896,000,000 | |
| 6,341,000,000 | |
| 5,974,000,000 | |
| 3,206,000,000 | |
| 3,882,000,000 | |
| 4,259,000,000 | |
| 4,825,000,000 | |
| 2,405,000,000 | |
| 1,145,000,000 | |
| 2,395,000,000 | |
| 2,527,000,000 | |
| 1,555,000,000 | |
| 1,393,000,000 | |
| 1,012,500,000 | |
| 524,000,000 | |
| 485,585,000 | |
| 470,195,000 | |
| 335,894,000 | |
| 262,475,000 | |
| 225,797,000 | |
| 173,000,000 | |
| 137,200,000 | |
| 134,300,000 | |
| 107,600,000 | |
| 72,800,000 | |
| 65,900,000 | |
| 52,900,000 | |
| 44,300,000 | |
| 30,300,000 | |
| 24,400,000 | |
| 15,400,000 |